首页 | 本学科首页   官方微博 | 高级检索  
     

丹参注射液与异甘草酸镁抗肝纤维化的临床对比研究
引用本文:华忠,胡泰洪,潘兆麟,朱银芳,顾锡炳,过小叶. 丹参注射液与异甘草酸镁抗肝纤维化的临床对比研究[J]. 国际流行病学传染病学杂志, 2007, 36(1): 158-159. DOI: 10.3760/cma.j.issn.1673-4149.2009.03.005
作者姓名:华忠  胡泰洪  潘兆麟  朱银芳  顾锡炳  过小叶
作者单位:无锡市传染病医院肝科四病区,214006;
摘    要:Objective To observe the change of liver function and liver fibrosis indexes of the chronic hepatitis B patients that were treated by Danshen injection(DI) and magnesium isnglyeyrrhizinate(MI). Methods 80 chronic hepati-tis B patients based on the conventional treatment were randomly divided into D1 group(40 patients) and MI group(40 pa-tients). The two groups were used with DI and MI injection for 30 days respaetively and then,the levels of liver function and serum hepatic fibrosis(HA, LN, Ⅳ -C) were detected and compared before and after treatment. Results Treatment by DI and MI could both improve liver function significantly, the effect of Ml group was better than DI group(P < 0.05). Moreover, in improving serum hepatic fibrosis, the effect of DI group was better than MI group (P < 0.05). Conclusions The efficacy of the improvement to hepatic fibrosis DI is better than MI, while in improvement of liver function MI is superior to DI.

关 键 词:肝纤维化   丹参注射液   异甘草酸镁   肝炎,乙型,慢性   

Compartive study of anti-hepatic fibrosis with Danshen injection and magnesium isoglycyrrhizinate
HUA Zhong,HU Tai-hong,PAN Zhao-lin,ZHU Yin-fang,CU Xi-bing,GUO Xiao-ye. Compartive study of anti-hepatic fibrosis with Danshen injection and magnesium isoglycyrrhizinate[J]. International Journal of Epidemiology and Infectious Disease, 2007, 36(1): 158-159. DOI: 10.3760/cma.j.issn.1673-4149.2009.03.005
Authors:HUA Zhong  HU Tai-hong  PAN Zhao-lin  ZHU Yin-fang  CU Xi-bing  GUO Xiao-ye
Abstract:
Keywords:Liver fibrosisDanshen injectionMagnesium isoglycyrrhizinateHepatitis B  chronic
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号